TherapeuticsMD (STU:29TA) Total Liabilities : €12.35 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is TherapeuticsMD Total Liabilities?

TherapeuticsMD's Total Liabilities for the quarter that ended in Mar. 2024 was €12.35 Mil.

TherapeuticsMD's quarterly Total Liabilities declined from Sep. 2023 (€21.03 Mil) to Dec. 2023 (€12.86 Mil) and declined from Dec. 2023 (€12.86 Mil) to Mar. 2024 (€12.35 Mil).

TherapeuticsMD's annual Total Liabilities declined from Dec. 2021 (€232.84 Mil) to Dec. 2022 (€52.22 Mil) and declined from Dec. 2022 (€52.22 Mil) to Dec. 2023 (€12.86 Mil).

TherapeuticsMD Total Liabilities Historical Data

The historical data trend for TherapeuticsMD's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TherapeuticsMD Total Liabilities Chart

TherapeuticsMD Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

231.11

251.21

232.84

52.22

12.86

TherapeuticsMD Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															25.76	20.76	21.03	12.86	12.35

TherapeuticsMD Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

TherapeuticsMD's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6.285	+	(5.99	+	0.583
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	12.86

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	39.714	-	26.856
	=	12.86

TherapeuticsMD's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5.951	+	(5.813	+	0.586
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	12.35

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	38.721	-	26.371
	=	12.35

TherapeuticsMD Total Liabilities Related Terms

Thank you for viewing the detailed overview of TherapeuticsMD's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

TherapeuticsMD (STU:29TA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TherapeuticsMD Inc (STU:29TA) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

TXMD:USA

Address

951 Yamato Road, Suite 220, Boca Raton, FL, USA, 33431

Website

https://www.therapeuticsmd.com

TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.

TherapeuticsMD (STU:29TA) Headlines

No Headlines